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Abstract
Background: Whole exome sequencing (WES) has been proven to serve as a valuable basis for various applications
such as variant calling and copy number variation (CNV) analyses. For those analyses the read coverage should be
optimally balanced throughout protein coding regions at sufficient read depth. Unfortunately, WES is known for its
uneven coverage within coding regions due to GC-rich regions or off-target enrichment.
Results: In order to examine the irregularities of WES within genes, we applied Agilent SureSelectXT exome capture
on human samples and sequenced these via Illumina in 2 × 101 paired-end mode. As we suspected the sequenced
insert length to be crucial in the uneven coverage of exome captured samples, we sheared 12 genomic DNA samples
to two different DNA insert size lengths, namely 130 and 170 bp. Interestingly, although mean coverages of target
regions were clearly higher in samples of 130 bp insert length, the level of evenness was more pronounced in 170 bp
samples. Moreover, merging overlapping paired-end reads revealed a positive effect on evenness indicating
overlapping reads as another reason for the unevenness.
In addition, mutation analysis on a subset of the samples was performed. In these isogenic subclones, the false
negative rate in the 130 bp samples was almost double to that in the 170 bp samples. Visual inspection of the
discarded mutation sites exposed low coverages at the sites flanked by high amplitudes of coverage depth.
Conclusions: Producing longer insert reads could be a good strategy to achieve better uniform read coverage in
coding regions and hereby enhancing the effective sequencing yield to provide an improved basis for further variant
calling and CNV analyses.
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Background
During the past years whole exome sequencing (WES)
has gained much popularity in research and diagnostics,
as focussing on protein-coding regions reduces sequenc-
ing costs compared to whole genome sequencing (WGS)
[1–4]. Concentrating on exonic regions minimises the
sequencing target area of the human genome with about
3 Gbp to less than 2 % [3, 4]. There is a broad applica-
tion area ofWES such as variant calling [3–5] and analysis
of copy number variations (CNV) [6, 7] demonstrating its
general usefulness in the genomic field.
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In terms of quality validation, many research efforts
were focussing on the comparison of different exome
enrichment platforms [8–11] and their performance to
WGS techniques [12, 13]. Apparently, one recurrent
bias appearing with WES is its inhomogeneous coverage
across targeted protein-coding regions, which is suggested
to be resolved by increasing read depth. However, increas-
ing depth for WES would also place the economic costs
for the alternative WGS in similar range to WES [12, 13].
For example, in one study the exome coverage of ≥20×
needed an average of 160× with WES, whereas WGS was
sufficient with 44-56× [12].
In the midst of this debate, we would like to propose
a new aspect to the technical side of WES. During stan-
dard WES (2 × 101 paired-end sequencing) of our cancer
cell lines, we observed a strong irregular distribution of
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read coverage along exons, which had a size of ≥1 kbp.
In the following, the genomic DNA fraction sequenced
as paired-end reads and flanked by illumina adapters
is denominated as insert, in order to confine these to
sequencing library fragments including illumina adapters.
Calculation of the original DNA insert size revealed that
the genomic DNA insert had a peak size of 130 bp.
This prompted us to consider, whether longer purified
DNA inserts might improve the evenness of read cov-
erage. In the past, DNA insert lengths of 200–250 bp
for 2 × 90 paired-end reads were mentioned to con-
tribute to library optimisation, nonetheless, results were
not shown [8]. Additionally, different fragmentation tech-
niques improved coverage, yet DNA insert length were
indicated for sonication (161 bp) but not for enzymatic
fragmentation [10]. In another study short inserts of 100–
200 bp are suggested instead of 500–800 bp [1], however,
at that time the development of exome capture design just
started and more importantly, very short single reads of
26 bp were analysed. Similarly, short reads of 35 and 50 bp
were sequenced for a further publication, in which short
insert sizes of 120 bp are recommended given the short
median length of 120 bp of human exons [14]. Appar-
ently, no specific study on the effect of DNA insert sizes
to paired-end sequencing has been published to date.
Therefore, we tested in this study, whether the genomic
DNA insert length influences the uniformity of read cov-
erage within targeted regions. Beside samples with 130
bp peak insert length, a sample group with 170 bp peak
inserts was produced and validated. The evenness score
[14] was applied as metric for assessing the effective-
ness of target region coverage. Altogether, we would like
to provide a short technical note on the effect of DNA
insert length on the evenness of coverage for paired-end
sequenced reads.
Results and discussion
Production of WES libraries with two different insert sizes
For exploring the effect of different genomic DNA insert
lengths on the uniformity of coverage in whole exome
sequencing (WES), we varied the DNA shearing by acous-
tic fragmentation (Covaris). Two DNA inserts groups of
six samples each were yielded with approximately 130 and
170 bp length (Fig. 1a+b). Exome enrichment was con-
ducted with Agilent SureSelectXT All Exon v5+UTR/v5
and sequencing produced 18–54 million reads per sam-
ple (see Table 1). After trimming, removing PCR dupli-
cates and mapping the reads to the human GENCODE
genome v21, manual inspection of alignments to many
exons exceeding 1 kbp indicated large amplitudes of cov-
erage for 130 bp compared to 170 bp samples (Fig. 1c).
This observation, that longer inserts might compensate
for “mountain-valley” profiles in coverage, encouraged us
to examine this in detail.
Since the mean DNA insert peak for each sample group
with 130 and 170 bp, respectively, was smaller than the
resulting paired-end sequenced reads of 2× 101 bp, a high
percentage of paired-end reads contained overlapping
sequences. As these overlaps did not contain further infor-
mation for e.g. variant calling and CNV analysis, paired-
end reads were joined where overlapping sequences were
found and aligned to the human genome. Trimming, read
mapping and joining statistics are summarised in Table 2
and Phred quality scores for the sequencing cycles are
visualised in Fig. 1d. Nearly all sequenced bases for further
analyses had quality scores ≥30.
In the following sections unmerged and merged
sequences are compared along with contrasting 130 ver-
sus 170 bp insert results.
Differences in exome capture and read depth
We applied two different exome enrichment kits in this
study, namely Agilent SureSelectXT v5+UTR and v5 on
the 130 bp genomic DNA insert and 170 bp group, respec-
tively (see Table 1). The genomic target region both kits
are covering were nearly identical except for the UTR
stretches which were exclusively contained in v5+UTR:
v5 target regions constitute 68 % of v5+UTR (75 Mb)
and 99.9996 % of v5 (50 Mb) were included in v5+UTR
(Fig. 2a). Hence, for further comparison the specific target
region needed to be considered.
Although aiming to adapt the read numbers to the
respective target regions during the sequencing process,
the mean coverage to the target region sizes 75 and 50
Mbp was increased for 130 bp compared to 170 bp inserts
(Fig. 2b). However, this difference attenuated when com-
puting coverage means for merged paired-end sequences.
Similar results were obtained when calculating the mean
coverage of 130 and 170 bp inserts on their respective tar-
get regions and on overlapping target regions of v5 and
v5+UTR (Fig. 2c). Intriguingly, concentrating on the frac-
tion in the respective target region at ≥10× read depth
revealed a smaller fraction of 130 bp samples covered at
that mininum read depth than for 170 bp (Fig. 2d). Low
coverages in turn mean impaired mutation detection in
these regions, whereas at the same time excessive cover-
age of target regions in 130 bp samples (Fig. 1c) seems
dispensible.
Comparing uniformity of coverage
As a measure for the skewed distribution of exome cap-
tured sequences in the coding regions, the evenness score
was calculated allowing for target region and library size
correction [14] (Fig. 3). Hereby, after normalising the
coverage of each sample to the integral for each cov-
erage curve to 1 (Fig. 3a+b), the area below the curve
between 0 and 1 is defined as the evenness score [14].
Bearing in mind that the higher the evenness score, the





Fig. 1 DNA shearing to 130 and 170 bp fractions before Illumina adapter ligation; sequencing base quality. a DNA insert length distribution per
sample. b Peak insert lengths for the two different sample groups. c Alignment histograms for 130 bp insert samples (red) exhibited high amplitudes
of coverage within the exon in comparison to 170 bp (blue) as exemplified by this gene BMP4 via IGV. Target regions of Agilent v5 and v5+UTR are
given in the last two lines. Please note the 3× fold higher maximum coverage of 130 bp samples. d High Phred score quality values for mapped
paired-end reads. Base calling quality was high after trimming and mapping to the human genome. As expected, for both reads in forward and
reverse direction (1–100 and 101–200 bases) read quality increased during the first 10 cycles and dropped gradually due to de-phasing errors of
Illumina’s sequencing pipeline. After joining paired-end reads, quality scores improved between 75–125 cycles, as the best scores were kept while
merging. Quality scores were ≥30 throughout nearly all cycles and similar between 130 and 170 bp samples
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Table 1 Portfolio of the samples in this study
Sample Cell line* Agilent Insert Mio.
SureSelectXT length bp Reads
HG3CD5n_cl1 HG3 v5+UTR 134 32.4
HG3CD5p_cl7 HG3 v5+UTR 132 44.4
U2932R1 U-2932 v5+UTR 131 44.1
U2932R2 U-2932 v5+UTR 133 53.8
WAC3CD5n WA-C3CD5+ v5+UTR 134 43.3
WAC3CD5p WA-C3CD5+ v5+UTR 130 35.9
HG3CD5n_cl41 HG3 v5 176 25.9
HG3CD5n_cl48 HG3 v5 167 27.9
HG3CD5n_mix HG3 v5 162 19.8
HG3CD5p_mix HG3 v5 163 21.8
NCNC NC-NC v5 171 22.2
WAOSEL WA-OSEL v5 174 18.0
*All cell lines are held at the DSMZ
more even the coverage, the evenness score for 170 bp
insert samples was clearly higher than 130 bp and hence
its coverage more even than the 130 bp group (Fig. 3c)
despite the higher average coverage of 130 bp (Fig. 2c).
Excluding overlapping sequences within the paired-end
reads yielded a substantial rise in evenness for both insert
groups.
Since using different enrichment kits for 130 and 170
bp samples respectively, the additional UTR target region
fraction might be the cause of the unevenness observed in
130 bp inserts. However, the differences in the evenness
scores were comparable to the results above when calcu-
lated on the common target region of v5 for both 130 and
170 bp inserts (Fig. 3c). The augmented evenness score
for 130 bp inserts in the common coding target regions
compared to its v5+UTR target region might even hint on
inferior read coverage in the UTRs or inversely enhanced
coverage (Fig. 2c) and uniformity for the coding regions.
ForWES applying paired-end sequencing, libraries with
small genomic DNA insert length produce overlapping
sequences. These overlapping bases within one paired-
end read provide no extra information on an alternate
DNA strand or another allele, since they stem from the
identical original genomicDNA sequence. Themore over-
lapping bases within a paired-end read, the more bases
remain unused, hence the effectivity to gain coverage
shrinks with low insert sizes. Moreover, joining paired-
end reads yielded in higher evenness scores particularly
for 130 bp inserts (Fig. 3c), thereby showing another
negative impact of redundant overlapping sequences.
On the other side, themedian size of human exons is 120
bp, thusmany bases will map off-target with longer inserts
[14], however, the coverage in longer exons would reach
higher uniformity and higher minimum depth (Fig. 2)
instead of distinct “mountain-valley” coverage silhouette.
Increasing coverage depth unfortunately would not yield
in proportionally homogeneous coverage (Fig. 2 and [12]).
Higher evenness in turn is prerequisite to effectively
detect mutations, which is achieved with longer inserts
(Fig. 3c). These longer inserts can be produced by a plain
technical adjustment in the DNA sample fragmentation
step. It may be speculated that peak library sizes of >200
bp will result in even better evenness and simultaneously
minimise costly overlapping read bases and reduce excess
coverages.
Missing mutations in shorter insert samples
To demonstrate that shorter DNA inserts do increase the
false negative rate for mutation analysis, we included four
isogenic subclones of the human cell line HG-3. All four
HG-3 subclones were sequenced at a comparable depth to
Table 2 Preprocessing statistics
Trimming R1 Trimming R2 Mapped Joined
Sample reads bases reads bases reads reads
HG3CD5n_cl1 19,9 % 9,0 22,4 % 22,2 93,7 % 80,5 %
HG3CD5p_cl7 20,0 % 8,8 22,4 % 22,1 93,6 % 82,4 %
U2932R1 20,1 % 8,9 22,1 % 21,8 93,5 % 81,9 %
U2932R2 20,0 % 8,9 22,6 % 22,8 93,7 % 80,1 %
WAC3CD5n 22,6 % 8,9 20,0 % 22,4 93,5 % 80,6 %
WAC3CD5p 20,0 % 9,0 22,4 % 21,8 93,7 % 81,6 %
HG3CD5n_cl41 14,6 % 12,8 12,7 % 43,1 90,5 % 38,0 %
HG3CD5n_cl48 14,5 % 12,6 12,5 % 42,7 90,3 % 47,1 %
HG3CD5n_mix 14,3 % 12,5 12,1 % 41,9 90,6 % 50,8 %
HG3CD5p_mix 13,7 % 12,3 11,9 % 42,4 91,0 % 46,8 %
NCNC 14,6 % 12,7 12,4 % 43,7 89,2 % 43,8 %
WAOSEL 13,3 % 15,9 10,3 % 42,4 88,0 % 44,4 %





Fig. 2 Target regions and relative read coverages. a Agilent
SureSelectXT v5+UTR target regions (75 Mb) consisted of 68 %
overlapping bases to v5 and a unique fraction of 32 %. The target
region of v5 (50 Mb) was nearly fully contained in v5+UTR. bMean
coverage of unmerged and merged paired-end reads considering the
size of respective target regions 75 and 50 Mbp for 130 bp and 170 bp,
respectively. The average coverage was higher in 130 bp inserts than
in 170 bp. This difference declined substantially when merging joint
paired-end reads. c Recalculation of coverage of unmerged and
merged paired-end reads on the respective specific target regions
and on common target regions only. The mean coverage on the
respective target regions was higher in 130 bp insert samples.
d Portion of respective target regions covered by at least 10×.
Despite higher coverage means for 130 bp, a smaller fraction of target
regions was apparent at ≥10× depth for 130 bp samples. For
overlapping target regions of v5 and v5+UTR the fraction of covered
regions was still not higher in 130 bp reads as would be implicated by
the higher coverage means
their respective target regions. Of 9087 mutations found
in at least one of the subclones, 223 and 193 were missed
in the 170 bp samples but nearly twice as many mutations
(540 and 375) in 130 bp (Fig. 4a), although coverage was
slightly higher in 130 bp inserts for common target coding
regions (Fig. 2c).
Manual inspection of 44 selected mutations with a min-
imum depth ≥20× in both 130 bp peak insert samples
and simultaneously <10× in 170 bp samples and vice
versa delivered mutations in four genes, that were dis-
carded by longer insert samples, but mutations in 20 genes
were missed by shorter inserts (e.g. Fig. 4b). Many of
the failed mutations by the shorter inserts were found in
regions, where amplitudes between maximum and min-
imum depth were high in the target regions forming a
“mountain-valley” pattern as for the mutation in OR5H15
(Fig. 4c). Although this mutation dropped out in the
shorter insert samples due to low depth in a “valley”, the
biallelic nature seen in the longer insert was also true
for shorter inserts. Here, higher coverage depth in target
regions for 130 bp samples could not improve muta-
tion detection in this gene. Expanding the insert length
resulted in mapping more reads to off-target regions of
OR5H15, which was more appropriate for this bait design.
The question arose whether the bait-balancing dif-
ferences between the two exome enrichment kits may
account for the skewed coverage of 130 bp compared to
170 bp samples. Bait-balancing is applied for adjusting
the number of probes to the binding efficiency of the
targeted regions. For OR5H15 as an example all cover-
age histogram peaks reflected the target regions, which
were identical to v5 and v5+UTR (Fig. 4c). An unopti-
mised bait-balance between the given oligos within this
single exon for both insert groups was apparent and the
bait-balance of the v5 and v5+UTR kit was similar if not
identical. It seems, that the manufacturer’s recommended
130–150 bp peak insert fragmentation was insufficient to
span the entire annotated exon of OR5H15 on the basis of
the target region rather than due to bait-balancing effects
of the different capture kits used.
To overcome this technical shortcoming, the baits of
the capture assay could be redesigned in closer proximity,
or the potential of the current platform could be exploited
by applying longer insert sizes. This would be a trade-off
between too low as well as excessive read coverages and
capturing off-target regions. Since flanking sequences to
target regions often reside within annotated gene regions,
achieving higher uniform coverage should be prioritised.
Conclusions
Although widely used, one major drawback of WES is its
skewed coverage distribution within the targeted exome.
By simply enlarging genomic DNA fragment sizes before
exome capturing, the evenness of coverage can be aug-
mented. We think that WES with an average coverage of
80x in contrast to WGS will remain feasible for smaller
studies with limited budget in the next years, therefore
any optimisation of this technology is assumed to affect a
broad community.
Hence, increasing the DNA insert length maybe even
longer than 170 bp will gain better uniform read coverage
for WES and thus provide an improved basis for variant
calling and CNV analyses at minimised sequencing costs.




Fig. 3 Evenness between different insert groups and unmerged/merged sequences. Before (a) and after (b) normalisation of coverage to the
fraction of respective target regions for unmerged sequences. The complete integral of normalised coverage to the target region is summing up to
1. c The evenness score computed from the area under the curve of unmerged (Fig. 3b) and merged sequences between 0 and 1 normalised
coverage. The closer the evenness score is to 1, the better the uniformity of base coverage. The impact of higher insert length was evident; merged
inserts gained top evenness scores regardless of relating to the specific corresponding target region or to overlapping target regions
Methods
Samples, exome enrichment and sequencing
A selection of 2 × 6 human cancer cell lines (see Table 1)
was prepared for WES all held by the DSMZ cell line
bank (http://www.dsmz.de) and cultured as described
previously [15].
Fragmentation of 100 ng purified genomic DNA
(gDNA) in 55 μl Tris-EDTA buffer was done on Covaris
S2 and the procedure adjusted to obtain fragments with a
peak length of 130 and 170 bp, respectively. After library
preparation from 100 ng of fragmented gDNA using Agi-
lent SureSelectXT v5 (50 Mb) and v5+UTR (75 Mb),
libraries were purified, size validated and prepared for
sequencing according to the manufacturer’s protocols.
Libraries were sequenced on Illumina HiSeq2500 using
TruSeq SBS Kit v3-HS (2 × 101, paired-end run). Con-
centration, quality, fragment sizes of purified genomic
DNA (gDNA) and libraries were controlled by Agilent
Technologies 2100 Bioanalyzer (Agilent Technologies;
Waldbronn, Germany).
Sequence processing, mapping and data analysis
Before mapping raw reads in fastq format, sequences
were trimmed at the ends for low quality (<Q20) or
adapter contamination by fastq-mcf of the ea-utils tool-
box (version 1.1.2-686). Subsequently, trimmed reads
were evaluated via FastQC (version 0.11.3, http://www.
bioinformatics.babraham.ac.uk/projects/fastqc). For ano-
ther branch of the pipeline trimmed reads were merged
via fastq-join of ea-utils (version 1.1.2-686). Alignments
of unmerged trimmed reads and merged reads were
carried out with STAR (version 2.4.1d) [16] to the
v21/hg38/GRCh38 assembly of the human reference
genome. After conversion of sam files to sorted bam
files by samtools (version 0.1.19), PCR duplicates were
removed via Picard tools (version 1.121, http://picard.
sourceforge.net).
For visual inspection of alignments the IGV was applied
[17]. Coverage was calculated by bedtools2 (version
2.19.1) based on the target region design Agilent pro-
vided at https://earray.chem.agilent.com/suredesign for




Fig. 4Missed mutations exemplified on four isogenic subclones. a The DNA of four isogenic subclones (human HG-3 cell line) were fragmented to
130 bp for HG3CD5n_cl1 and HG3CD5p_cl7 and to 170 bp peak insert sizes for HG3CD5n_cl41 and HG3CD5n_cl48. Several mutations were missed
by variant calling for samples fragmented to 130 bp, but clearly less for 170 bp. b Example mutation on gene OR5H15 (red arrow) with coverage
depth of 6× and 2× for 130 bp and 40× and 35× depth for 170 bp insert samples. OR5H15 does not contain any UTRs in this single 900 bp exon.
Reads were sorted in IGV to bases at the mutation site, hence all detected Ts for 130 bp samples (3 and 1, respectively) are indicated. c Specific
target regions of v5+UTR and v5 in gene OR5H15 were identical to which the coverage histogram peaks map. Target regions are given in the last
two lines. The amplitudes were higher for the 130 bp samples as well as the maximum read depth in the visible region compared to 170 bp
samples. At the same time pronounced amplitudes were also obvious for 170 bp within the gene region of OR5H15 implying that sequencing
longer DNA fragments would have gained even smaller amplitudes and a higher coverage across the gene region. The four subclones carried four
further mutations (grey arrows) beside the failed mutation of 130 bp samples (red arrow) indicating sequence similarity of the subclones
Agilent SureSelect All Exon v5 (S04380110) and Agilent
SureSelect All Exon v5+UTR (S04380219). These files
were converted to gencode v21 coordinates by the UCSC
liftover tool and files (https://genome-store.ucsc.edu/).
Insert sizes were determined by Picard tools. Graphs were
created in the R/Bioconductor environment (http://www.
bioconductor.org/) in particular applying ggplot2 [18]. For
comparability the evenness score [14] served as metrics
for the uniform coverage in the target regions.
Variant calling was conducted by VarScan 2 [19]
to identify mutations in four subclones of the HG-
3 cell line with a minimum depth of 10× and 2×
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for an alternative allele. The four subclones were
HG3CD5n_cl1 and HG3CD5p-cl7 for 130 bp peak insert
sizes and HG3CD5n_cl41 and HG3CD5n_cl48 for 170
bp (see Table 1). Afterwards, the Variant Effect Predictor
(release 77, http://www.ensembl.org/info/docs/tools/vep/
index.html) helped to concentrate on mutations in coding
regions with severe consequences such as missense and
stop gained effects.
Data were deposited at ArrayExpress under the acces-
sion number E-MTAB-4527.
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